(R)-4-(5-(3-Chloro-4-(methylsulfonyl)phenyl)-1,3,4-oxadiazol-2-yl)-N-(1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethyl)benzamide

ID: ALA4127446

Chembl Id: CHEMBL4127446

PubChem CID: 145960880

Max Phase: Preclinical

Molecular Formula: C27H20Cl3N5O4S

Molecular Weight: 616.91

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CS(=O)(=O)c1ccc(-c2nnc(-c3ccc(C(=O)N[C@@H](Cn4ccnc4)c4ccc(Cl)cc4Cl)cc3)o2)cc1Cl

Standard InChI:  InChI=1S/C27H20Cl3N5O4S/c1-40(37,38)24-9-6-18(12-22(24)30)27-34-33-26(39-27)17-4-2-16(3-5-17)25(36)32-23(14-35-11-10-31-15-35)20-8-7-19(28)13-21(20)29/h2-13,15,23H,14H2,1H3,(H,32,36)/t23-/m0/s1

Standard InChI Key:  DYSKNETXBJKLOF-QHCPKHFHSA-N

Alternative Forms

  1. Parent:

    ALA4127446

    ---

Associated Targets(non-human)

ERG11 Cytochrome P450 51 (617 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Lanosterol 14-alpha demethylase (57 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 616.91Molecular Weight (Monoisotopic): 615.0302AlogP: 6.14#Rotatable Bonds: 8
Polar Surface Area: 119.98Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 6.78CX LogP: 4.42CX LogD: 4.36
Aromatic Rings: 5Heavy Atoms: 40QED Weighted: 0.22Np Likeness Score: -1.52

References

1. Friggeri L, Hargrove TY, Wawrzak Z, Blobaum AL, Rachakonda G, Lindsley CW, Villalta F, Nes WD, Botta M, Guengerich FP, Lepesheva GI..  (2018)  Sterol 14α-Demethylase Structure-Based Design of VNI (( R)- N-(1-(2,4-Dichlorophenyl)-2-(1 H-imidazol-1-yl)ethyl)-4-(5-phenyl-1,3,4-oxadiazol-2-yl)benzamide)) Derivatives To Target Fungal Infections: Synthesis, Biological Evaluation, and Crystallographic Analysis.,  61  (13): [PMID:29894182] [10.1021/acs.jmedchem.8b00641]

Source